"The trouble is that the market is changing much faster than most marketers realize."
"Customer service is more than just a nice-to-have. In this competitive marketplace, it can mean the difference between your brand or someone else's."
"We are living in an era of great medical technological innovations. However, this is shifting healthcare back home and expecting patients to understand excessive medical information and follow complex instructions."
"In this era, it requires mobilizing our collective intelligence toward innovation and integration that is meaningful for large populations."
There needs to be a greater effort put into the issue of adherence. What can academia, providers, pharma and payers do to address this pressing need?
Once we venerated doctors. Now we question every dollar they make
I come not to bury government but to praise it—at least the singular agency I know best: FDA
Success today is predicated on recognizing that every patient is different, every disease is different, every drug, every breakthrough and every cure is different.
"Today's conversations between sales reps and their HCP customers often include talk about a drug's savings offer. And on the non-personal/digital front, many of pharma's biggest brands are putting cost savings front and center."
It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing
Demonizing new treatments distracts from the real problem: policies that focus on the near-term
Gen Y wants companies to stand for "Important missions and values"
Is there anything that pharma can do to make doctors' lives easier?
These multi-dimensional, surround-sound experiences suck you right in for living, breathing engagement
The next generations will engage with the digital world in a way that could effect real change in breast cancer.
Using the same methods they use to stimulate demand for a brand, agencies can educate communities and ultimately transform how countries approach healthcare, urges H.E. Toyin Saraki.
Health apps become multilingual
The pharmaceutical industry's need for promotional spending has never been greater
Apple's official entry into the health wearables market indicates they've taken on a considerable, new design challenge: health behavior change.
Any time a firm needs to save money, high-salaried executives are targets
These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.
Give the cool 20% of your audience cool stuff, like apps. Relate to the other 80% in ways that are less cool
A level of trust happens when you have an in-person relationship that just can't be recreated online
A charge of sexism against the FDA clouds the views surrounding a drug's application
Satisfaction levels among pharma-based respondents fell, but didn't exactly tank
The great thing about TEDMED—the promise of the brand—is that it will inspire you to see the world differently. On this most important score, TEDMED succeeded in some spectacular ways.
Today, we're all still trying to get people to buy our drugs and be a trusted health advisor, but these two goals seem to be working firmly against each other.
To find stability, children's hospitals must offer value to today's more empowered healthcare consumers. This requires building strong relationships with moms—specifically millennial moms.
Stream Health, WPP's "unconference" which took place in Florida earlier this week, provided a diverse and large amount of content in a short amount of time.
What's happening in the pharmacy business is a study in leadership, with important lessons for pharma
With wearable technology, digital health has moved past content we can search, share and engage with to something far more personal—defining ourselves as the data that we track, analyze and share.
Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike
Problems and changes have set ablaze criticism over the Sunshine Act's implementation
Companies are realizing that they need to be more attuned to their audience
It may be time to adopt a model in which we help deliver healthcare
What good is information, if it forgoes the emotion that moves people to take action? Enter visual storytelling—an emerging art form designed to conjure up narratives through stirring imagery and simple messaging.
In the past for patients, the equation was simple: go to your doctor, receive a diagnosis, pick up a prescription, and adhere. Today, consumers face a very different reality.
This year, FDA has finally begun to offer some guidance to marketers about digital media. Here's what social patients say they want
Influential patients are reaching critical mass. What can't they do?
Though critically important, eSampling is best used as part of an integrated marketing strategy and sample distribution program.
The way in which consumers will perceive adaptive marketing is going to depend crucially on our motives.
Dan Chichester, chief creative officer, LLNS
When you have a successful brand, you tamper with it at your peril
We cemented our credibility during the most difficult period for publishing
What happens when it's the FDA—not a medical marketer—that is doing the overstating?
Don't waste another minute or dollar on your brand standards manual. It's painfully irrelevant
The differences that can be made by meaningful use are ones that need some time to make themselves felt
Lessons can be learned from the reality TV shows currently dominating the nation's airwaves.
Some recommendations to help marketers put their best foot forward on smartphone and tablet screens
What does it take to turn your booth into a world-class educational and entertainment experience? Here are five proven principles that consistently bring the magic to the show floor.
"Behavior design" is beginning to make its way into pharma.
Want to give better creative feedback? Try P&G's uncommon-sense process.
A major partnership between Merck and PatientsLikeMe tests how a new kind of online evidence network could inform drug development using real-world health outcomes
What's "comfortable" in the US might be interpreted as "pain-free" In Finland. Why adapting medical messages into other languages takes precision
What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?
Since when was the US better at soccer than advertising?
Consumers tend to be more honest with their social postings than they are with their doctor or insurer. That may lead to a lot more insight for pharma
A US Pharma juror's—and silver Lions Health winner's—opinion on why the Americans didn't fare well in Cannes, and tips for improvement
How the torrent of news from these tech titans may change the near-term realities on the ground for pharma and medical device companies
The recent ONC report on regulation of health IT, such as mobile medical apps, raises lots of questions but illustrates the hurdles to drafting practical guidance
Three AbelsonTaylor executives discuss how Apple's new HealthKit and Health apps will shape our industry
What the recent Samsung and Apple announcements about health technology tell us about the future of mobile health solutions
Cancer drugs with Breakthrough status have a shortened timeframe within which to develop a value proposition and price point that can be defended
The challenge of communications and marketing in the strange new world of the Affordable Care Act
The NEJM Group, the organization behind the New England Journal of Medicine and NEJM Journal Watch, has launched a tool that seeks to infuse the NEJM brand across a medical professional's career.
We identify not with just the product, but with what it represents
Promotions and hires for manufacturers, agencies and technology companies
Evan Young, associate creative director, Renavatio Healthcare Communications.
The new information age in which we live has made it unnecessary for patients to "live in the dark"
Digital collaboration platforms make it convenient for pharma and thought leaders to engage
Nineteen Republicans on the House Energy and Commerce Committee want FDA commissioner Margaret Hamburg to explain the role the American Association for Justice (trial lawyers) played in drafting proposed changes to generic drug labeling.
A Manhattan Institute analysis says that helping underperforming FDA drug review divisions match the output of high-performing divisions could cut development costs and speed approval of new treatments.
A patient who is diagnosed earlier and receives the most efficacious treatment is the least expensive
Access to payers is about knowledge, about understanding what they do in their jobs
News on Symphony Health Solutions, Wolters Kluwer Health and Frontline Medical Communications
The iPad and iPhone resource from Medscape has one purpose: to funnel medical news to a professional's device
At MM&M's Leadership Exchange, the passion, candor, enthusiasm and respect were second-to-none
Executives from Ironwood Pharmaceuticals describe an approach that promises to improve point-of-care interactions
Global execs from Novartis and Mundipharma discuss the role creativity can play in healthcare marketing
Some key questions pharmaceutical marketers should ask before making decisions about which online and offline consumer channels to pursue
Visual communications provide the opportunity to dramatically reshape and improve how patients learn about conditions and care.
A general consensus is that a "shake-up" of some kind is coming
Promotions and hires for manufacturers and agencies
How can testimonials make their mark in a branded space? By getting real.
You have to approach quality assurance as an intrinsic part of the process, not an afterthought
Specialty brands ignore more than 50% of the specialists they serve, so 50% of the audience is wide open
Former Speaker of the House and presidential candidate Newt Gingrich has declared that it's time to replace FDA
FDA has insisted that its antique regulations can address every new promotional challenge
Should pharma formulate a super matrix to determine the FMV of research incentives?
News on BMJ, MedPage Today and John Wiley & Sons
When it comes to the patent cliff, pharma, it seems, is so over it
What brand managers need to know to achieve data security maturity
Express Scripts warned of building an anti-Sovaldi coalition. If payers are unwilling to pay for such drugs, or band against their makers, where does pharma go from here?
Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.
Medscape's survey of over 24,000 physicians found that a paycheck is not necessarily linked to a physician's professional satisfaction.
Nine things CMOs should consider when desiring to engage consumers who no longer want to give their attention to boring and scripted product descriptions.
Are today's young adults on their way to healthier lives in middle age and beyond? New data from GfK's Roper Diabetes study series gives cause for concern.
There's no cure. But the good news is that prophylaxis is possible.
Promotions and hires for manufacturers and agencies
Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.